Azitra, Inc. (AZTR)
0.1716
0.00 (0.00%)
USD |
NYAM |
Sep 21, 16:00
0.1716
0.00 (0.00%)
After-Hours: 20:00
Azitra Enterprise Value : 4.227M for Sept. 18, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 18, 2026 | 4.227M |
| September 17, 2026 | 4.470M |
| September 16, 2026 | 3.524M |
| September 15, 2026 | 4.046M |
| September 14, 2026 | 4.318M |
| September 11, 2026 | 4.476M |
| September 10, 2026 | 4.597M |
| September 09, 2026 | 4.476M |
| September 08, 2026 | 4.106M |
| September 04, 2026 | 4.561M |
| September 03, 2026 | 4.591M |
| September 02, 2026 | 4.652M |
| September 01, 2026 | 4.391M |
| August 31, 2026 | 4.288M |
| August 28, 2026 | 4.403M |
| August 27, 2026 | 4.942M |
| August 26, 2026 | 4.161M |
| August 25, 2026 | 3.227M |
| August 24, 2026 | 2.797M |
| August 21, 2026 | 1.730M |
| August 20, 2026 | 1.361M |
| August 19, 2026 | 1.270M |
| August 18, 2026 | 1.258M |
| August 17, 2026 | 1.882M |
| August 14, 2026 | 2.124M |
| Date | Value |
|---|---|
| August 13, 2026 | 2.167M |
| August 12, 2026 | 1.864M |
| August 11, 2026 | 2.355M |
| August 10, 2026 | 2.167M |
| August 07, 2026 | 1.864M |
| August 06, 2026 | 1.852M |
| August 05, 2026 | 2.106M |
| August 04, 2026 | 2.040M |
| August 03, 2026 | 1.712M |
| July 31, 2026 | 1.724M |
| July 30, 2026 | 1.621M |
| July 29, 2026 | 1.440M |
| July 28, 2026 | 1.567M |
| July 27, 2026 | 1.415M |
| July 24, 2026 | 1.336M |
| July 23, 2026 | 1.379M |
| July 22, 2026 | 1.573M |
| July 21, 2026 | 1.906M |
| July 20, 2026 | 2.530M |
| July 17, 2026 | 2.106M |
| July 16, 2026 | 1.730M |
| July 15, 2026 | 1.870M |
| July 14, 2026 | 1.482M |
| July 13, 2026 | 1.567M |
| July 10, 2026 | 2.288M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Tenax Therapeutics, Inc. | -57.27M |
| Exicure, Inc. | 6.123M |
| Century Therapeutics, Inc. | 254.77M |
| Absci Corp. | 1.458B |
| Celularity, Inc. | 106.32M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.348M |
| Total Expenses (Quarterly) | 3.348M |
| EPS Diluted (Quarterly) | -0.1734 |
| Earnings Yield | -761.0% |
| Normalized Earnings Yield | -761.01 |